Similar Items: CRISPRi mediated investigation of the vulnerability of two essential cell wall biosynthetic gene products in mycobacteria.
- Surveillance of antibiotic prescribing practices and trends of resistance at a private hospital in Zimbabwe
- CRISPR interference screening model organisms for TB drugs development.
- Expanding the scope of bacterial pantothenate kinase inhibitors for application in antibacterial drug development
- The antimycobacterial activity of phytocannabinoids
- Resistance to the novel nitroimidazole drug class in Mycobacterium tuberculosis
- Effect of oxidative stress on MEP pathway dependent enzyme and cytokinin production in Mycobacteria